Patent · US Active

Antiviral nucleosides

US7754699B2 · kind B2 · utility

64Cited by
6References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 8, 2006
Grant dateJul 13, 2010
Priority date—
Expiry dateOct 29, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds having the formula I wherein R1 is as herein defined are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for inhibiting hepatitis replication, and processes for making the compounds of formula I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.